{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:08:37Z","timestamp":1769321317716,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12033-021-00411-x","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T06:13:29Z","timestamp":1632896009000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Innovations in CRISPR-Based Therapies"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-1460","authenticated-orcid":false,"given":"Gokul","family":"Kesavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"1","key":"411_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","volume":"36","author":"FJ Mojica","year":"2000","unstructured":"Mojica, F. J., D\u00edez-Villase\u00f1or, C., Soria, E., & Juez, G. (2000). Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria. Molecular Microbiology, 36(1), 244\u2013246. https:\/\/doi.org\/10.1046\/j.1365-2958.2000.01838.x","journal-title":"Molecular Microbiology"},{"issue":"4","key":"411_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/crispr.2020.0025","volume":"3","author":"LS Tay","year":"2020","unstructured":"Tay, L. S., Palmer, N., Panwala, R., Chew, W. L., & Mali, P. (2020). Translating CRISPR-Cas therapeutics: Approaches and challenges. The CRISPR Journal, 3(4), 253\u2013275. https:\/\/doi.org\/10.1089\/crispr.2020.0025","journal-title":"The CRISPR Journal"},{"key":"411_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00247-9","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Wen, R., Yang, Z., & Chen, Z. (2021). Genome editing using CRISPR\/Cas9 to treat hereditary hematological disorders. Gene Therapy. https:\/\/doi.org\/10.1038\/s41434-021-00247-9","journal-title":"Gene Therapy"},{"issue":"4","key":"411_CR4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/jcp.30064","volume":"236","author":"B Zhang","year":"2021","unstructured":"Zhang, B. (2021). CRISPR\/Cas gene therapy. Journal of Cellular Physiology, 236(4), 2459\u20132481. https:\/\/doi.org\/10.1002\/jcp.30064","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"411_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1631\/jzus.B2100009","volume":"22","author":"C Li","year":"2021","unstructured":"Li, C., Brant, E., Budak, H., & Zhang, B. (2021). CRISPR\/Cas: A Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement. Journal of Zhejiang University-SCIENCE B, 22(4), 253\u2013284. https:\/\/doi.org\/10.1631\/jzus.B2100009","journal-title":"Journal of Zhejiang University-SCIENCE B"},{"issue":"11","key":"411_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41580-020-00288-9","volume":"21","author":"H Zhu","year":"2020","unstructured":"Zhu, H., Li, C., & Gao, C. (2020). Applications of CRISPR\u2013Cas in agriculture and plant biotechnology. Nature Reviews Molecular Cell Biology, 21(11), 661\u2013677. https:\/\/doi.org\/10.1038\/s41580-020-00288-9","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"4","key":"411_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.tim.2014.01.007","volume":"22","author":"J Bondy-Denomy","year":"2014","unstructured":"Bondy-Denomy, J., & Davidson, A. R. (2014). To acquire or resist: The complex biological effects of CRISPR\u2013Cas systems. Trends in Microbiology, 22(4), 218\u2013225. https:\/\/doi.org\/10.1016\/j.tim.2014.01.007","journal-title":"Trends in Microbiology"},{"key":"411_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01387","author":"F Uddin","year":"2020","unstructured":"Uddin, F., Rudin, C. M., & Sen, T. (2020). CRISPR gene therapy: Applications, limitations, and implications for the future. Frontiers in Oncology. https:\/\/doi.org\/10.3389\/fonc.2020.01387","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"411_CR9","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1038\/s41467-020-17418-8","volume":"11","author":"S-H Kang","year":"2020","unstructured":"Kang, S.-H., Lee, W., An, J.-H., Lee, J.-H., Kim, Y.-H., Kim, H., Oh, Y., Park, Y.-H., Jin, Y. B., Jun, B.-H., Hur, J. K., Kim, S.-U., & Lee, S. H. (2020). Prediction-based highly sensitive CRISPR off-target validation using target-specific DNA enrichment. Nature Communications, 11(1), 3596. https:\/\/doi.org\/10.1038\/s41467-020-17418-8","journal-title":"Nature Communications"},{"issue":"8","key":"411_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","volume":"24","author":"CA Vakulskas","year":"2018","unstructured":"Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., Lee, C. M., Park, S. H., Wiebking, V., Bak, R. O., Gomez-Ospina, N., Pavel-Dinu, M., Sun, W., Bao, G., Porteus, M. H., & Behlke, M. A. (2018). A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine, 24(8), 1216\u20131224. https:\/\/doi.org\/10.1038\/s41591-018-0137-0","journal-title":"Nature Medicine"},{"issue":"1","key":"411_CR11","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/s41598-018-38189-9","volume":"9","author":"H Sun","year":"2019","unstructured":"Sun, H., & Yu, G. (2019). New insights into the pathogenicity of non-synonymous variants through multi-level analysis. Scientific Reports, 9(1), 1667. https:\/\/doi.org\/10.1038\/s41598-018-38189-9","journal-title":"Scientific Reports"},{"issue":"7681","key":"411_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017). Programmable base editing of A\u00b7T to G\u00b7C in genomic DNA without DNA cleavage. Nature, 551(7681), 464\u2013471. https:\/\/doi.org\/10.1038\/nature24644","journal-title":"Nature"},{"issue":"7603","key":"411_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 533(7603), 420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"issue":"12","key":"411_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020). Base editing: Advances and therapeutic opportunities. Nature Reviews Drug Discovery, 19(12), 839\u2013859. https:\/\/doi.org\/10.1038\/s41573-020-0084-6","journal-title":"Nature Reviews Drug Discovery"},{"issue":"7785","key":"411_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., & Liu, D. R. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576(7785), 149\u2013157. https:\/\/doi.org\/10.1038\/s41586-019-1711-4","journal-title":"Nature"},{"key":"411_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.58","author":"W-J Dai","year":"2016","unstructured":"Dai, W.-J., Zhu, L.-Y., Yan, Z.-Y., Xu, Y., Wang, Q.-L., & Lu, X.-J. (2016). CRISPR-Cas9 for in vivo gene therapy: Promise and hurdles. Molecular Therapy - Nucleic Acids. https:\/\/doi.org\/10.1038\/mtna.2016.58","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"5\u20136","key":"411_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/hum.2021.013","volume":"32","author":"I Dasgupta","year":"2021","unstructured":"Dasgupta, I., Flotte, T. R., & Keeler, A. M. (2021). CRISPR\/Cas-dependent and nuclease-free in vivo therapeutic gene editing. Human Gene Therapy, 32(5\u20136), 275\u2013293. https:\/\/doi.org\/10.1089\/hum.2021.013","journal-title":"Human Gene Therapy"},{"key":"411_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/978-1-4614-3209-8_66","volume":"801","author":"TG Drivas","year":"2014","unstructured":"Drivas, T. G., & Bennett, J. (2014). CEP290 and the primary cilium. Advances in Experimental Medicine and Biology, 801, 519\u2013525. https:\/\/doi.org\/10.1007\/978-1-4614-3209-8_66","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"11","key":"411_CR19","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/hmg\/ddl107","volume":"15","author":"B Chang","year":"2006","unstructured":"Chang, B., Khanna, H., Hawes, N., Jimeno, D., He, S., Lillo, C., Parapuram, S. K., Cheng, H., Scott, A., Hurd, R. E., Sayer, J. A., Otto, E. A., Attanasio, M., O\u2019Toole, J. F., Jin, G., Shou, C., Hildebrandt, F., Williams, D. S., Heckenlively, J. R., & Swaroop, A. (2006). In-frame deletion in a novel centrosomal\/ciliary protein CEP290\/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse. Human Molecular Genetics, 15(11), 1847\u20131857. https:\/\/doi.org\/10.1093\/hmg\/ddl107","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"411_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1086\/507318","volume":"79","author":"AI den Hollander","year":"2006","unstructured":"den Hollander, A. I., Koenekoop, R. K., Yzer, S., Lopez, I., Arends, M. L., Voesenek, K. E. J., Zonneveld, M. N., Strom, T. M., Meitinger, T., Brunner, H. G., Hoyng, C. B., van den Born, L. I., Rohrschneider, K., & Cremers, F. P. M. (2006). Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. American Journal of Human Genetics, 79(3), 556\u2013561. https:\/\/doi.org\/10.1086\/507318","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"411_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., Dass, A., Dhanapal, V., Fennell, T. J., Friedland, A. E., Giannoukos, G., Gloskowski, S. W., Glucksmann, A., Gotta, G. M., Jayaram, H., \u2026, Jiang, H","year":"2019","unstructured":"Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., Dass, A., Dhanapal, V., Fennell, T. J., Friedland, A. E., Giannoukos, G., Gloskowski, S. W., Glucksmann, A., Gotta, G. M., Jayaram, H., \u2026, Jiang, H. (2019). Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nature Medicine, 25(2), 229\u2013233. https:\/\/doi.org\/10.1038\/s41591-018-0327-9","journal-title":"Nature Medicine"},{"issue":"7859","key":"411_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"Musunuru, K., Chadwick, A. C., Mizoguchi, T., Garcia, S. P., DeNizio, J. E., Reiss, C. W., Wang, K., Iyer, S., Dutta, C., Clendaniel, V., Amaonye, M., Beach, A., Berth, K., Biswas, S., Braun, M. C., Chen, H.-M., Colace, T. V., Ganey, J. D., Gangopadhyay, S. A., \u2026, Kathiresan, S","year":"2021","unstructured":"Musunuru, K., Chadwick, A. C., Mizoguchi, T., Garcia, S. P., DeNizio, J. E., Reiss, C. W., Wang, K., Iyer, S., Dutta, C., Clendaniel, V., Amaonye, M., Beach, A., Berth, K., Biswas, S., Braun, M. C., Chen, H.-M., Colace, T. V., Ganey, J. D., Gangopadhyay, S. A., \u2026, Kathiresan, S. (2021). In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature, 593(7859), 429\u2013434. https:\/\/doi.org\/10.1038\/s41586-021-03534-y","journal-title":"Nature"},{"key":"411_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00933-4","author":"Rothgangl, T., Dennis, M. K., Lin, P. J. C., Oka, R., Witzigmann, D., Villiger, L., Qi, W., Hruzova, M., Kissling, L., Lenggenhager, D., Borrelli, C., Egli, S., Frey, N., Bakker, N., Walker, J. A., Kadina, A. P., Victorov, D. V., Pacesa, M., Kreutzer, S., \u2026, Schwank, G","year":"2021","unstructured":"Rothgangl, T., Dennis, M. K., Lin, P. J. C., Oka, R., Witzigmann, D., Villiger, L., Qi, W., Hruzova, M., Kissling, L., Lenggenhager, D., Borrelli, C., Egli, S., Frey, N., Bakker, N., Walker, J. A., Kadina, A. P., Victorov, D. V., Pacesa, M., Kreutzer, S., \u2026, Schwank, G. (2021). In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-021-00933-4","journal-title":"Nature Biotechnology"},{"issue":"48","key":"411_CR24","doi-asserted-by":"publisher","first-page":"50630","DOI":"10.1074\/jbc.M410077200","volume":"279","author":"SW Park","year":"2004","unstructured":"Park, S. W., Moon, Y.-A., & Horton, J. D. (2004). Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver. Journal of Biological Chemistry, 279(48), 50630\u201350638. https:\/\/doi.org\/10.1074\/jbc.M410077200","journal-title":"Journal of Biological Chemistry"},{"key":"411_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107454","author":"Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O\u2019Connell, D., Walsh, K. R., Wood, K., Phillips, J., Xu, Y., Amaral, A., Boyd, A. P., Cehelsky, J. E., McKee, M. D., Schiermeier, A., Harari, O., Murphy, A., \u2026, Lebwohl, D","year":"2021","unstructured":"Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O\u2019Connell, D., Walsh, K. R., Wood, K., Phillips, J., Xu, Y., Amaral, A., Boyd, A. P., Cehelsky, J. E., McKee, M. D., Schiermeier, A., Harari, O., Murphy, A., \u2026, Lebwohl, D. (2021). CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2107454","journal-title":"New England Journal of Medicine"},{"issue":"7843","key":"411_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"Koblan, L. W., Erdos, M. R., Wilson, C., Cabral, W. A., Levy, J. M., Xiong, Z.-M., Tavarez, U. L., Davison, L. M., Gete, Y. G., Mao, X., Newby, G. A., Doherty, S. P., Narisu, N., Sheng, Q., Krilow, C., Lin, C. Y., Gordon, L. B., Cao, K., Collins, F. S., \u2026, Liu, D. R","year":"2021","unstructured":"Koblan, L. W., Erdos, M. R., Wilson, C., Cabral, W. A., Levy, J. M., Xiong, Z.-M., Tavarez, U. L., Davison, L. M., Gete, Y. G., Mao, X., Newby, G. A., Doherty, S. P., Narisu, N., Sheng, Q., Krilow, C., Lin, C. Y., Gordon, L. B., Cao, K., Collins, F. S., \u2026, Liu, D. R. (2021). In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature, 589(7843), 608\u2013614. https:\/\/doi.org\/10.1038\/s41586-020-03086-7","journal-title":"Nature"},{"key":"411_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03609-w","author":"Newby, G. A., Yen, J. S., Woodard, K. J., Mayuranathan, T., Lazzarotto, C. R., Li, Y., Sheppard-Tillman, H., Porter, S. N., Yao, Y., Mayberry, K., Everette, K. A., Jang, Y., Podracky, C. J., Thaman, E., Lechauve, C., Sharma, A., Henderson, J. M., Richter, M. F., Zhao, K. T., \u2026, Liu, D. R","year":"2021","unstructured":"Newby, G. A., Yen, J. S., Woodard, K. J., Mayuranathan, T., Lazzarotto, C. R., Li, Y., Sheppard-Tillman, H., Porter, S. N., Yao, Y., Mayberry, K., Everette, K. A., Jang, Y., Podracky, C. J., Thaman, E., Lechauve, C., Sharma, A., Henderson, J. M., Richter, M. F., Zhao, K. T., \u2026, Liu, D. R. (2021). Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature. https:\/\/doi.org\/10.1038\/s41586-021-03609-w","journal-title":"Nature"},{"issue":"2","key":"411_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/humu.21660","volume":"33","author":"R Huijgen","year":"2012","unstructured":"Huijgen, R., Sjouke, B., Vis, K., de Randamie, J. S. E., Defesche, J. C., Kastelein, J. J. P., Hovingh, G. K., & Fouchier, S. W. (2012). Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels. Human Mutation, 33(2), 448\u2013455. https:\/\/doi.org\/10.1002\/humu.21660","journal-title":"Human Mutation"},{"key":"411_CR29","doi-asserted-by":"publisher","unstructured":"Chemello, F., Chai, A. C., Li, H., Rodriguez-Caycedo, C., Sanchez-Ortiz, E., Atmanli, A., Mireault, A. A., Liu, N., Bassel-Duby, R., & Olson, E. N. (2021). Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Science Advances, 7(18), eabg4910. https:\/\/doi.org\/10.1126\/sciadv.abg4910","DOI":"10.1126\/sciadv.abg4910"},{"key":"411_CR30","doi-asserted-by":"publisher","unstructured":"Amoasii, L., Hildyard, J. C. W., Li, H., Sanchez-Ortiz, E., Mireault, A., Caballero, D., Harron, R., Stathopoulou, T.-R., Massey, C., Shelton, J. M., Bassel-Duby, R., Piercy, R. J., & Olson, E. N. (2018). Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science (New York, N.Y.), 362(6410), 86\u201391. https:\/\/doi.org\/10.1126\/science.aau1549","DOI":"10.1126\/science.aau1549"},{"key":"411_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8081","author":"L Amoasii","year":"2017","unstructured":"Amoasii, L., Long, C., Li, H., Mireault, A. A., Shelton, J. M., Sanchez-Ortiz, E., McAnally, J. R., Bhattacharyya, S., Schmidt, F., Grimm, D., Hauschka, S. D., Bassel-Duby, R., & Olson, E. N. (2017). Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Science Translational Medicine. https:\/\/doi.org\/10.1126\/scitranslmed.aan8081","journal-title":"Science Translational Medicine"},{"key":"411_CR32","doi-asserted-by":"publisher","unstructured":"Tabebordbar, M., Zhu, K., Cheng, J. K. W., Chew, W. L., Widrick, J. J., Yan, W. X., Maesner, C., Wu, E. Y., Xiao, R., Ran, F. A., Cong, L., Zhang, F., Vandenberghe, L. H., Church, G. M., & Wagers, A. J. (2016). In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science (New York, N.Y.), 351(6271), 407\u2013411. https:\/\/doi.org\/10.1126\/science.aad5177","DOI":"10.1126\/science.aad5177"},{"issue":"3","key":"411_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., Ho, T. W., Kattamis, A., Kernytsky, A., Lekstrom-Himes, J., Li, A. M., Locatelli, F., Mapara, M. Y., de Montalembert, M., Rondelli, D., \u2026, Corbacioglu, S","year":"2021","unstructured":"Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., Ho, T. W., Kattamis, A., Kernytsky, A., Lekstrom-Himes, J., Li, A. M., Locatelli, F., Mapara, M. Y., de Montalembert, M., Rondelli, D., \u2026, Corbacioglu, S. (2021). CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. New England Journal of Medicine, 384(3), 252\u2013260. https:\/\/doi.org\/10.1056\/NEJMoa2031054","journal-title":"New England Journal of Medicine"},{"key":"411_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365","author":"Stadtmauer, E. A., Fraietta, J. A., Davis, M. M., Cohen, A. D., Weber, K. L., Lancaster, E., Mangan, P. A., Kulikovskaya, I., Gupta, M., Chen, F., Tian, L., Gonzalez, V. E., Xu, J., Jung, I., Melenhorst, J. J., Plesa, G., Shea, J., Matlawski, T., Cervini, A., \u2026, June, C. H","year":"2020","unstructured":"Stadtmauer, E. A., Fraietta, J. A., Davis, M. M., Cohen, A. D., Weber, K. L., Lancaster, E., Mangan, P. A., Kulikovskaya, I., Gupta, M., Chen, F., Tian, L., Gonzalez, V. E., Xu, J., Jung, I., Melenhorst, J. J., Plesa, G., Shea, J., Matlawski, T., Cervini, A., \u2026, June, C. H. (2020). CRISPR-engineered T cells in patients with refractory cancer. Science. https:\/\/doi.org\/10.1126\/science.aba7365","journal-title":"Science"},{"issue":"1","key":"411_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41232-020-00132-9","volume":"40","author":"K Koga","year":"2020","unstructured":"Koga, K., Wang, B., & Kaneko, S. (2020). Current status and future perspectives of HLA-edited induced pluripotent stem cells. Inflammation and Regeneration, 40(1), 23. https:\/\/doi.org\/10.1186\/s41232-020-00132-9","journal-title":"Inflammation and Regeneration"},{"issue":"1","key":"411_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/STJ-200002","volume":"2","author":"TB Meissner","year":"2020","unstructured":"Meissner, T. B., & Cowan, C. A. (2020). More bang for your buck: \u201cOff-The-Shelf\u201d solutions for cell replacement therapy. StemJournal, 2(1), 1\u20135. https:\/\/doi.org\/10.3233\/STJ-200002","journal-title":"StemJournal"},{"issue":"4","key":"411_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., Kitaoka, F., Takahashi, T., Okita, K., Yoshida, Y., Kaneko, S., & Hotta, A. (2019). Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell, 24(4), 566-578.e7. https:\/\/doi.org\/10.1016\/j.stem.2019.02.005","journal-title":"Cell Stem Cell"},{"issue":"2","key":"411_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.117.306290","volume":"117","author":"P Abrahimi","year":"2015","unstructured":"Abrahimi, P., Chang, W. G., Kluger, M. S., Qyang, Y., Tellides, G., Saltzman, W. M., & Pober, J. S. (2015). Efficient gene disruption in cultured primary human endothelial cells by CRISPR\/Cas9. Circulation Research, 117(2), 121\u2013128. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.306290","journal-title":"Circulation Research"},{"issue":"12","key":"411_CR39","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","volume":"19","author":"R Lanza","year":"2019","unstructured":"Lanza, R., Russell, D. W., & Nagy, A. (2019). Engineering universal cells that evade immune detection. Nature Reviews. Immunology, 19(12), 723\u2013733. https:\/\/doi.org\/10.1038\/s41577-019-0200-1","journal-title":"Nature Reviews. Immunology"},{"issue":"7","key":"411_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaoncol.2018.0977","volume":"4","author":"I Hernandez","year":"2018","unstructured":"Hernandez, I., Prasad, V., & Gellad, W. F. (2018). Total costs of chimeric antigen receptor T-cell immunotherapy. JAMA Oncology, 4(7), 994\u2013996. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0977","journal-title":"JAMA Oncology"},{"issue":"9","key":"411_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/tvst.9.9.17","volume":"9","author":"MF Uhrmann","year":"2020","unstructured":"Uhrmann, M. F., Lorenz, B., & Gissel, C. (2020). Cost effectiveness of voretigene neparvovec for RPE65-mediated inherited retinal degeneration in Germany. Translational Vision Science & Technology, 9(9), 17\u201317. https:\/\/doi.org\/10.1167\/tvst.9.9.17","journal-title":"Translational Vision Science & Technology"},{"issue":"4","key":"411_CR42","first-page":"667","volume":"90","author":"JS Sherkow","year":"2017","unstructured":"Sherkow, J. S. (2017). CRISPR, patents, and the public health. The Yale Journal of Biology and Medicine, 90(4), 667\u2013672.","journal-title":"The Yale Journal of Biology and Medicine"},{"issue":"9","key":"411_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature Biotechnology, 31(9), 822\u2013826. https:\/\/doi.org\/10.1038\/nbt.2623","journal-title":"Nature Biotechnology"},{"issue":"20","key":"411_CR44","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1093\/nar\/gkt714","volume":"41","author":"TJ Cradick","year":"2013","unstructured":"Cradick, T. J., Fine, E. J., Antico, C. J., & Bao, G. (2013). CRISPR\/Cas9 systems targeting \u03b2-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Research, 41(20), 9584\u20139592. https:\/\/doi.org\/10.1093\/nar\/gkt714","journal-title":"Nucleic Acids Research"},{"issue":"7629","key":"411_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., Uchida, N., Hendel, A., Narla, A., Majeti, R., Weinberg, K. I., & Porteus, M. H. (2016). CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature, 539(7629), 384\u2013389. https:\/\/doi.org\/10.1038\/nature20134","journal-title":"Nature"},{"issue":"8","key":"411_CR46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","volume":"20","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver, A., & Gersbach, C. A. (2019). The next generation of CRISPR\u2013Cas technologies and applications. Nature Reviews Molecular Cell Biology, 20(8), 490\u2013507. https:\/\/doi.org\/10.1038\/s41580-019-0131-5","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7","key":"411_CR47","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3390\/cells9071608","volume":"9","author":"M Naeem","year":"2020","unstructured":"Naeem, M., Majeed, S., Hoque, M. Z., & Ahmad, I. (2020). Latest developed strategies to minimize the off-target effects in CRISPR-Cas-mediated genome editing. Cells, 9(7), 1608. https:\/\/doi.org\/10.3390\/cells9071608","journal-title":"Cells"},{"issue":"1","key":"411_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13059-018-1534-x","volume":"19","author":"F Alkan","year":"2018","unstructured":"Alkan, F., Wenzel, A., Anthon, C., Havgaard, J. H., & Gorodkin, J. (2018). CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters. Genome Biology, 19(1), 177. https:\/\/doi.org\/10.1186\/s13059-018-1534-x","journal-title":"Genome Biology"},{"issue":"1","key":"411_CR49","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1038\/s41467-020-17952-5","volume":"11","author":"MA Coelho","year":"2020","unstructured":"Coelho, M. A., De Braekeleer, E., Firth, M., Bista, M., Lukasiak, S., Cuomo, M. E., & Taylor, B. J. M. (2020). CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs. Nature Communications, 11(1), 4132. https:\/\/doi.org\/10.1038\/s41467-020-17952-5","journal-title":"Nature Communications"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-021-00411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-021-00411-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-021-00411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T04:22:48Z","timestamp":1673842968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-021-00411-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1007\/s12033-021-00411-x","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}